Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling

10.1016/j.canlet.2017.12.030

Saved in:

Bibliographic Details
Main Authors:	Wang, Lingzhi, Syn, Nicholas Li-Xun, Subhash, Vinod Vijay, Any, Yijia, Thuya, Win Lwin, Cheow, Esther Sok Hwee, Kong, Li Ren, Yu, Fenggang, Peethala, Praveen C., Wong, Andrea Li-Ann, Laljibhai, Hirpara J., Chinnathambi, Arunachalam, Ong, Pei Shi, Ho, Paul Chi-Lui, Sethi, Gautam, Yong, Wei Peng, Goh, Boon Cher
Other Authors:	PHARMACOLOGY
Format:	Article
Language:	English
Published:	ELSEVIER IRELAND LTD 2020
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Panobinostat Histone deacetylase inhibitors LBH589 Non-small cell lung cancer Epigenetic therapy HISTONE DEACETYLASE INHIBITORS DNA-DAMAGE 1ST-LINE TREATMENT OPEN-LABEL PHASE-I CHEMOTHERAPY MULTICENTER ERLOTINIB METAANALYSIS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/175506
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-175506
record_format	dspace
spelling	sg-nus-scholar.10635-1755062024-11-13T22:56:02Z Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling Wang, Lingzhi Syn, Nicholas Li-Xun Subhash, Vinod Vijay Any, Yijia Thuya, Win Lwin Cheow, Esther Sok Hwee Kong, Li Ren Yu, Fenggang Peethala, Praveen C. Wong, Andrea Li-Ann Laljibhai, Hirpara J. Chinnathambi, Arunachalam Ong, Pei Shi Ho, Paul Chi-Lui Sethi, Gautam Yong, Wei Peng Goh, Boon Cher PHARMACOLOGY MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE PHARMACY Dr Liren Kong Science & Technology Life Sciences & Biomedicine Oncology Panobinostat Histone deacetylase inhibitors LBH589 Non-small cell lung cancer Epigenetic therapy HISTONE DEACETYLASE INHIBITORS DNA-DAMAGE 1ST-LINE TREATMENT OPEN-LABEL PHASE-I CHEMOTHERAPY MULTICENTER ERLOTINIB METAANALYSIS 10.1016/j.canlet.2017.12.030 CANCER LETTERS 417 152-160 2020-09-10T01:55:38Z 2020-09-10T01:55:38Z 2018-03-28 2020-09-09T22:28:53Z Article Wang, Lingzhi, Syn, Nicholas Li-Xun, Subhash, Vinod Vijay, Any, Yijia, Thuya, Win Lwin, Cheow, Esther Sok Hwee, Kong, Li Ren, Yu, Fenggang, Peethala, Praveen C., Wong, Andrea Li-Ann, Laljibhai, Hirpara J., Chinnathambi, Arunachalam, Ong, Pei Shi, Ho, Paul Chi-Lui, Sethi, Gautam, Yong, Wei Peng, Goh, Boon Cher (2018-03-28). Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling. CANCER LETTERS 417 : 152-160. ScholarBank@NUS Repository. https://doi.org/10.1016/j.canlet.2017.12.030 03043835 18727980 https://scholarbank.nus.edu.sg/handle/10635/175506 en ELSEVIER IRELAND LTD Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology Panobinostat Histone deacetylase inhibitors LBH589 Non-small cell lung cancer Epigenetic therapy HISTONE DEACETYLASE INHIBITORS DNA-DAMAGE 1ST-LINE TREATMENT OPEN-LABEL PHASE-I CHEMOTHERAPY MULTICENTER ERLOTINIB METAANALYSIS
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology Panobinostat Histone deacetylase inhibitors LBH589 Non-small cell lung cancer Epigenetic therapy HISTONE DEACETYLASE INHIBITORS DNA-DAMAGE 1ST-LINE TREATMENT OPEN-LABEL PHASE-I CHEMOTHERAPY MULTICENTER ERLOTINIB METAANALYSIS Wang, Lingzhi Syn, Nicholas Li-Xun Subhash, Vinod Vijay Any, Yijia Thuya, Win Lwin Cheow, Esther Sok Hwee Kong, Li Ren Yu, Fenggang Peethala, Praveen C. Wong, Andrea Li-Ann Laljibhai, Hirpara J. Chinnathambi, Arunachalam Ong, Pei Shi Ho, Paul Chi-Lui Sethi, Gautam Yong, Wei Peng Goh, Boon Cher Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
description	10.1016/j.canlet.2017.12.030
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Wang, Lingzhi Syn, Nicholas Li-Xun Subhash, Vinod Vijay Any, Yijia Thuya, Win Lwin Cheow, Esther Sok Hwee Kong, Li Ren Yu, Fenggang Peethala, Praveen C. Wong, Andrea Li-Ann Laljibhai, Hirpara J. Chinnathambi, Arunachalam Ong, Pei Shi Ho, Paul Chi-Lui Sethi, Gautam Yong, Wei Peng Goh, Boon Cher
format	Article
author	Wang, Lingzhi Syn, Nicholas Li-Xun Subhash, Vinod Vijay Any, Yijia Thuya, Win Lwin Cheow, Esther Sok Hwee Kong, Li Ren Yu, Fenggang Peethala, Praveen C. Wong, Andrea Li-Ann Laljibhai, Hirpara J. Chinnathambi, Arunachalam Ong, Pei Shi Ho, Paul Chi-Lui Sethi, Gautam Yong, Wei Peng Goh, Boon Cher
author_sort	Wang, Lingzhi
title	Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
title_short	Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
title_full	Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
title_fullStr	Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
title_full_unstemmed	Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling
title_sort	pan-hdac inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of egfr signaling
publisher	ELSEVIER IRELAND LTD
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/175506
_version_	1821200772280352768

Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling

Similar Items